ライフサイエンスコーパス: enroll

1 ib, and had Child-Pugh A liver function were enrolled.

2 rved by EMS (1971 rural and 65076 urban) was enrolled.

3 , severity of sepsis and renal function were enrolled.

4 A total of 1350 patients with cirrhosis were enrolled.

5 onths since their last previous therapy were enrolled.

6 cystoid macular edema (CME) of >300 mum were enrolled.

7 ubjects (30 patients and 20 surrogates) were enrolled.

8 Twenty-four patients were enrolled.

9 008, and February 8, 2013, 344 patients were enrolled.

10 s, 73% male, 30% ischemic pathogenesis) were enrolled.

11 were not receiving anti-HBV prophylaxis were enrolled.

12 mean baseline oxygen saturation, 96.6%) were enrolled.

13 ched healthy controls (n = 14; 28 eyes) were enrolled.

14 segment-elevation myocardial infarction were enrolled.

15 orn at 30 + 0 to 36 + 6 wk of gestation were enrolled.

16 events occurred, both for the first patient enrolled.

17 al of 251 participants (458 study eyes) were enrolled.

18 healthy control subjects were consecutively enrolled.

19 days to 18 years old with septic shock were enrolled.

20 Fifty-four NAFLD patients were consecutively enrolled.

21 Tc sestamibi scintigraphy were prospectively enrolled.

22 homa, and chronic lymphocytic leukemia, were enrolled.

23 ly confirmed metastatic ocular melanoma were enrolled.

24 A total of 130 healthy Chinese subjects were enrolled.

25 Sixty patients were enrolled.

26 We included 13 trials enrolling 1,652 patients.

27 Of the 41 men enrolled, 1 did not receive any protocol treatment and w

28 We enrolled 10 SCA38 patients, and carried out a double-bli

29 The authors prospectively enrolled 105 patients admitted for AF ablation.

30 Twenty-seven patients were enrolled: 11 during dose escalation (6 at 4.0 mg and 5 a

31 Between Jan 16, 2007, and Dec 17, 2013, we enrolled 12 patients who were randomly assigned either t

32 Of the 17 patients enrolled, 12 (71%) were men; mean (SD) age was 45.2 (14.

33 e sites participating in TENOR II originally enrolled 1230 patients in TENOR I.

34 We enrolled 18 consecutive patients meeting study criteria

35 Of the 201 patients enrolled, 190 patients with an adequate baseline CT perf

36 5, we screened 414 patients and subsequently enrolled 229 cases with P knowlesi malaria mono-infectio

37 A total of 446 patients were enrolled; 233 (52.2%) were male, and the mean (SD) age w

38 lts The dose-escalation and expansion phases enrolled 26 and 25 patients, respectively.

39 We enrolled 26 participants and tested 130 seminal fluid sp

40 We enrolled 30 patients with mild-to-moderate AD in a rando

41 We enrolled 32 men with BCR of PCa, who were 59-83 y old (m

42 METHODS AND We enrolled 335 consecutive valvular heart disease subjects

43 Between Aug 1, 2015, and Jan 29, 2016, we enrolled 345 eligible transwomen.

44 Between Dec 29, 2014, and May 3, 2016, we enrolled 35 patients, of whom 32 (91%) underwent randomi

45 SCORE2 enrolled 362 participants, including 305 with CRVO and 5

46 ween Nov 4, 2010, and Dec 7, 2015, the trial enrolled 399 patients and was terminated after a planned

47 We enrolled 4,556 infants that were at least 2,000 g at bir

48 We enrolled 40 children aged 9 to 36 months with suspected

49 observational multicenter cohort study that enrolled 4062 patients aged >/=18 years with AMI between

50 We enrolled 4093 postmenopausal women with osteoporosis and

51 61 patients were enrolled, 42 were HLA matched and 19 were haploidentical

52 The study enrolled 4232 hospitalized cases and 5325 controls over

53 arallel, multinational lipid-lowering trials enrolling 4300 patients with hyperlipidemia who were ran

54 Between April 6, 2009, and Jan 3, 2012, we enrolled 452 patients (225 [50%] in the two chemotherapy

55 from four case-control studies that together enrolled 4726 participants with coronary heart disease a

56 These exiting plans enrolled 4848310 Medicaid beneficiaries, with a mean of

57 A total of 100 infants were enrolled; 51 were randomly assigned to undergo ETV-CPC,

58 , 2012, and Sept 15, 2014, 107 patients were enrolled: 54 on the 5-day schedule (26 randomly assigned

59 om the NIH-AARP Diet and Health Study, which enrolled 566,407 persons who were 50-71 y old at baselin

60 We enrolled 5823 patients within 1 year (with 98% follow-up

61 aving implantable cardiac defibrillator were enrolled: 63 (group 1) having documented ventricular tac

62 were randomized, and 1,297 individuals were enrolled (646 in the laboratory arm, 651 in the POC arm)

63 Of 732 patients enrolled, 730 were included in the final analysis.

64 We enrolled 786 505 (64.2%) were adults and 281 (35.8%) wer

65 We enrolled 94 subjects who were microbiologically classifi

66 This prospective observational cohort study enrolled a consecutive sample of 318 AII-eligible inpati

67 We enrolled a convenience sample of 220 adult male survivor

68 rials Network for HIV/AIDS Interventions 113 enrolled a diverse sample of adolescent MSM at risk for

69 oss-sectional study, What About Youth, which enrolled a random sample of 298 080 school pupils drawn

70 prospective randomized phase III trials that enrolled a total of 6,081 patients-COU-AA-301, AFFIRM, E

71 We enrolled adult patients (aged >/=18 years) who had cytol

72 , randomised, phase 3, multicentre trial, we enrolled adult patients with CD30-positive mycosis fungo

73 , multicentre, open-label, phase 2 trial, we enrolled adults (aged >/=18 years) with histologically c

74 ticenter study of 8 EDs in the United States enrolled adults with a recent suicide attempt or ideatio

75 rom 1996 to April 25, 2016, for studies that enrolled adults with cirrhosis awaiting LT and treated w

76 d healthy adults with normal cognition and 5 enrolled adults with MCI.

77 hylactic ICD implantation were prospectively enrolled (age 62+/-11 years, left ventricular ejection f

78 The G-ROP Study enrolled all infants undergoing ROP examinations with a

79 24, 2015, and Aug 8, 2016, 374 patients were enrolled and 370 patients received at least one dose of

80 4, 2002, and Oct 8, 2010, 1347 patients were enrolled and 676 were eligible for random allocation, 59

81 psed or refractory mantle cell lymphoma were enrolled and all patients received treatment; median age

82 s with testing ordered for C. difficile were enrolled and assigned a high, medium, or low pretest pro

83 e expending >/=3 METs, 46 [21, 92] min) were enrolled and assigned to the intervention (n = 76) or co

84 a sampling at day 7 in the first 10 patients enrolled and by sparse sampling in all patients througho

85 thousand two hundred fifty-one patients were enrolled and followed for a median of 3.4 years.

86 th or without intervention was prospectively enrolled and followed for incident type 1 and T2MI, and

87 15, we screened 26 children, of whom 23 were enrolled and initiated treatment.

88 ec 5, 2007, and Oct 8, 2012, 4884 women were enrolled and randomised after exclusion of patients at a

89 dinopathy diagnosed at US were prospectively enrolled and randomized.

90 Between Oct 28, 2013, and July 29, 2015, we enrolled and randomly allocated 377 participants (188 [5

91 1680 participants were enrolled and randomly allocated between May 30, 2008, an

92 In group 1, patients were enrolled and randomly assigned in a 3:1 ratio to receive

93 6, 2011, and Jan 22, 2014, 640 patients were enrolled and randomly assigned to a treatment group (317

94 Feb 29, and July 9, 2012, 727 patients were enrolled and randomly assigned to ipilimumab 10 mg/kg (3

95 0, 2011, and Nov 16, 2015, 194 patients were enrolled and randomly assigned to SRS (98 patients) or W

96 Of 577 eligible patients, 377 (65.3%) were enrolled and randomly assigned to the mHELP (n = 197; me

97 3, 2010, and Jan 20, 2014, 257 patients were enrolled and randomly assigned to the two treatment grou

98 2015, and Nov 4, 2016, 112 participants were enrolled and randomly assigned; 34 to the control group,

99 We screened 39 patients, of whom 37 were enrolled and received at least one dose of nivolumab.

100 March 30 and Nov 28, 2014, 235 patients were enrolled and received at least one dose of study drug.

101 16, 2014, and Dec 28, 2015, 36 patients were enrolled and treated with first-line dabrafenib plus tra

102 A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral sh

103 ith an indication for coronary stenting were enrolled, and 11648 (mean age, 61.3 years; 25.1% female)

104 7, a population-based screening project that enrolled around 1.7 million community-dwelling adults ag

105 ial, HIV-1-infected adults were screened and enrolled at 119 hospitals in 11 countries in North Ameri

106 (including ventilator-associated pneumonia), enrolled at 136 centres in 23 countries, were randomly a

107 ate response to topical corticosteroids were enrolled at 161 hospitals, clinics, and academic institu

108 466 were contacted again, and 373 (80%) were enrolled at 21.2 +/- 3.5 years of age.

109 4, or 5 non-dialysis-dependent CKD, who were enrolled at 3 US medical centers.

110 Two patients enrolled at a higher dose of 1000 mg/m(2), and both had

111 secutive hospitalized patients with CAP were enrolled at all adult hospitals in Louisville.

112 n = 759) was taken from a prospective cohort enrolled at another academic medical center ICU for whom

113 ects (43 subjects with normal findings) were enrolled at four institutions.

114 Eligible patients had been enrolled at one centre in the AURA study, had shown resi

115 AND Between 2014 and 2016, 537 patients were enrolled at our center, and 202 patients received Lotus

116 48% of participants were women, and 77% were enrolled at the U.S. sites.

117 150/2 remained in the study (13 [24%] of 54 enrolled at this dose plus five [11%] of 45 initially ad

118 tment for baseline characteristics, patients enrolled based on previous revascularization for periphe

119 tion, and stroke when compared with patients enrolled based on the ankle-brachial index criterion.

120 e Latino children (8-15 years; n = 314) were enrolled between 2001 and 2012 from Los Angeles, CA, and

121 1800 participants were enrolled between Dec 5, 2014, and Feb 13, 2015.

122 refractory acute myeloid leukemia (AML) were enrolled between January 2013 and June 2014 to receive 4

123 and not currently receiving lamotrigine were enrolled between July 18, 2013, and January 19, 2015.

124 cts, undergoing chemotherapy for DLBCL, were enrolled between June 2015 and December 2015.

125 lth facilities (20 clusters) in South Africa enrolled between June 8, and Nov 16, 2012, to estimate t

126 256 patients were screened and 206 were enrolled between Oct 30, 2013, and Dec 19, 2014.

127 2 patients with central RVO or hemi-RVO were enrolled between September 17, 2014, and November 18, 20

128 astatic clear cell renal cell carcinoma were enrolled between September 2012 and April 2014 from 17 l

129 A total of 41 men were enrolled between the trial's activation on August 9, 201

130 We enrolled cases with microscopy-positive, PCR-confirmed m

131 From 14 top enrolling centers, 128 of 175 patients identified with a

132 d and nonrandomized comparative studies that enrolled children and adolescents with confirmed diagnos

133 e Deficiency Treatment Consortium (PIDTC) is enrolling children with severe combined immunodeficiency

134 ed for more than 4 days from a prospectively enrolled cohort of consecutive adults in the mixed ICUs

135 uccessful Aging after Elective Surgery study enrolled dementia-free adults >/=70 years old undergoing

136 ts were 27 078 white and black men and women enrolled during 2002 to 2009 in the SCCS (Southern Commu

137 28 participants with CIC were enrolled during the same period and 27 received study tr

138 y-eight consecutive CC patients (706 F) were enrolled (FC 62.5%, IBS-C 31.3%, NRC 6.2%).

139 In this case-control study, we enrolled febrile patients presenting to outpatient depar

140 Among participants enrolled for >/=8 d (n = 66), higher early energy intake

141 ing Gram-negative bacilli were prospectively enrolled for this study.

142 Patients were enrolled from 179 research sites in 7 countries from Feb

143 ents aged 4 to 13 years with asthma who were enrolled from 37 inner-city elementary schools in the no

144 Eligible patients were enrolled from 58 centres across 18 countries and randoml

145 ours or longer under general anesthesia were enrolled from December 4, 2012, through August 28, 2016

146 d secondary analysis of a prospective cohort enrolled from January 1 through December 31, 2011, and f

147 cipants with chronic HBV infection that were enrolled from January 20, 2011, to October 2, 2013, were

148 with moderate to severe acute extremity pain enrolled from July 2015 to August 2016.

149 -proven HCC and who were undergoing TAE were enrolled from October 15, 2014, through December 2, 2015

150 y sampled group of non-assault-injured youth enrolled from September 2009 through December 2011.

151 -five percent or more of study patients were enrolled from the United States for a prespecified subgr

152 In stage 2 of the study (reported here), we enrolled healthy adolescents who had received three dose

153 11 trials with low or medium risk of bias, 6 enrolled healthy adults with normal cognition and 5 enro

154 d in Uganda, Zimbabwe, Malawi, and Kenya, we enrolled HIV-infected adults and children 5 years of age

155 rallel-group randomized controlled trial, we enrolled household shoppers across New Zealand who owned

156 having a first-degree relative with T1D were enrolled if they had 1 of 9 HLA genotypes associated wit

157 a functioning graft at 2 years consented to enroll in an observational, noninterventional extension

158 o were male and nonwhite were less likely to enroll in hospice and more likely to receive chemotherap

159 ohort study, 496 patients with acute HF were enrolled in 14 hospitals in the Netherlands between 2009

160 alth Study, a prospective cohort of AA women enrolled in 1995 and followed biennially.

161 Households in these villages were enrolled in 2013 for a baseline survey, then re-enrolled

162 olled in 2013 for a baseline survey, then re-enrolled in 2015 for an endline survey.

163 ) head injury cohort study included patients enrolled in 25 North American emergency departments from

164 at approximately 12 wk gestation among women enrolled in a 10-city Canadian cohort study.

165 f 15 subjects (5 normal and 10 dry eye) were enrolled in a 3-visit study consisting of 1 screening an

166 We studied patients enrolled in a Danish nationwide register who underwent i

167 Participants with mild asthma were enrolled in a double-blinded, placebo-controlled crossov

168 uary 1, 2000, through December 31, 2009, and enrolled in a follow-up substudy a mean (SD) of 10 (3) m

169 r extreme risk by the local heart teams were enrolled in a global pilot study at 14 sites (United Sta

170 In an additional 138 patients enrolled in a pharmacokinetic and pharmacodynamic substu

171 ixty subjects of age 60 years and above were enrolled in a population-based, cross-sectional study.

172 tients presenting with ST were prospectively enrolled in a registry by using a centralized telephone

173 nalysis of CAIS was conducted among children enrolled in a single-center prospective consecutive coho

174 HIV-infected participants enrolled in a study of cerebrospinal fluid (CSF) abnorma

175 ars or younger with newly diagnosed diabetes enrolled in a US managed care network from January 1, 20

176 th homozygous familial hypercholesterolaemia enrolled in an open-label, non-randomised phase 3 trial.

177 A total of 361 consecutive patients enrolled in any 1 of 9 US multicenter cancer treatment t

178 Of 71 patients enrolled in AURA, 53 were eligible for this analysis.

179 -7.9) and 88 (15%) versus 19 (3%) were newly enrolled in care (4.4, 2.6-7.4).

180 arch 2014 and January 2015, 388 participants enrolled in Check Hep C, 129 (33%) initiated treatment,

181 is from a total of 84 patients who have been enrolled in clinical trials for Progeria at Boston Child

182 lure with reduced ejection fraction who were enrolled in clinical trials, a finding that is consisten

183 ies (37507 with at least 1 diagnosis of ASD) enrolled in commercial health care insurance plans at a

184 ective cohort study of children continuously enrolled in coverage from the Alabama Medicaid Agency fr

185 Medicaid beneficiaries enrolled in exiting plans had access to coverage for a h

186 ], 234 with Crohn's disease [CD]; 236 male), enrolled in Germany from August 2013 through April 2014

187 duals who were aware of their status but not enrolled in HIV care (change in mean HRQoL -0.004, 95% C

188 009, and December 31, 2009, who subsequently enrolled in hospice between July 1, 2009, and December 3

189 ving 1,325,563 pregnancies in women who were enrolled in Medicaid and who delivered a live-born infan

190 adjustment for confounders, whites with OAG enrolled in Medicaid had 198% higher odds of receiving n

191 Children aged 5 to 19 enrolled in Medicaid in 2009 to 2010 were included.

192 RPRETATION: Patients with diabetes and HFrEF enrolled in PARADIGM-HF who received sacubitril/valsarta

193 Among the 8399 patients enrolled in PARADIGM-HF, 7623 (91%) completed KCCQ score

194 were screened, of whom 152 participants were enrolled in part 1 of this study.

195 72 (89.1%) of 4232 suspected pneumonia cases enrolled in PERCH.

196 Women were enrolled in Right from the Start (2004-2010) prospective

197 Patients assigned to lanadelumab were enrolled in sequential dose groups: total dose of 30 mg

198 5, 2011, 11 897 HIV-seronegative adults were enrolled in SHIMS and 11 232 (94%) were re-tested.

199 ion of the 471 patients with ME/CFS who were enrolled in stage 1.

200 ol system in Framingham, Massachusetts, were enrolled in the 8th or 9th grade (baseline; mean [SD] ag

201 Patients enrolled in the African American Study of Kidney Disease

202 We now assess HSCT in patients enrolled in the ASTIC trial using endpoints that are tra

203 studies, we examined results of participants enrolled in the Botswana TDF/FTC Oral HIV Prophylaxis Tr

204 Children enrolled in the CAP (Caffeine for Apnea of Prematurity)

205 Children enrolled in the Childhood Origins of ASThma study were f

206 y-two thousand six hundred eight individuals enrolled in the cohort, and 11,193 completed a home visi

207 spring Cohort of Framingham Heart Study were enrolled in the current study.

208 This analysis included 211 women enrolled in the Environment And Reproductive Health (EAR

209 This cohort was 60.1% of the 2358 children enrolled in the Etiology of Pneumonia in the Community S

210 A further 114 infants were enrolled in the expanded cohort between Nov 3, 2014, and

211 All participants who enrolled in the extension with observed data were includ

212 itively normal (CN) subsample of 144 adults, enrolled in the Ginkgo Evaluation of Memory study at a u

213 April 25, 2009, and March 25, 2010, who were enrolled in the Growing Up in New Zealand study.

214 tched historical control patients previously enrolled in the HMII (HeartMate II) clinical trials, non

215 samples from 69 liver transplant recipients enrolled in the Immune Tolerance Network immunosuppressi

216 Infants enrolled in the Infant Aphakia Treatment Study (IATS).

217 wise selection) using data from 401 patients enrolled in the international randomized International E

218 m 977 prevalent kidney transplant recipients enrolled in the Malnutrition-Inflammation in Transplant-

219 patients with acute coronary syndrome (ACS) enrolled in the MATRIX-Access (Minimizing Adverse Haemor

220 METHODS AND We evaluated 789 Marfan patients enrolled in the National Heart, Lung, and Blood Institut

221 evaluated within 5 years from symptom onset, enrolled in the Natural History Project of the Dystonia

222 a on 68,514 women (mean age, 65 +/- 7 years) enrolled in the Nurses' Health Study since 2000 and 28,9

223 ,983 participants 40 to 54 years of age were enrolled in the PESA (Progression of Early Subclinical A

224 ed data from echocardiograms of all patients enrolled in the Placement of Aortic Transcatheter Valves

225 ed sputum microscopy and culture in patients enrolled in the Pneumonia Etiology Research for Child He

226 The median number of participants enrolled in the preapproval studies was 132 (interquarti

227 Of 2472 children enrolled in the prospective cohort (1100 with acute otit

228 sis and high/intermediate surgical risk were enrolled in the registry at 51 sites in the United State

229 IEN 3 transcatheter aortic valve replacement enrolled in the RESOLVE study (Assessment of Transcathet

230 Children enrolled in the School Inner-City Asthma Study were foll

231 d 1 Asian) with symptomatic Weiss rings were enrolled in the study (mean [SD] age, 61.4 [8.0] years f

232 ase-causing variants in ABCA4 (OMIM 601691), enrolled in the study from 9 centers between August 2, 2

233 Of 1205 participants enrolled in the study, 922 had classic Rett syndrome, an

234 on-small cell lung cancer were prospectively enrolled in the study.

235 .0% female) and 6558 children (48.7% female) enrolled in the TEDDY study who were tested for islet an

236 symptoms suggestive of hypogonadism who were enrolled in the Testosterone Trials between June 24, 201

237 myocardial infarction (MI) of 12365 patients enrolled in the Treatment With Adenosine Diphosphate Rec

238 Among the 104 patients enrolled in the trial, 52% had genotype 1 infection, 16%

239 (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial.

240 ith primary immunodeficiency diseases (PIDD) enrolled in the United States Immune Deficiency Network

241 Black (n = 496) and White (n = 196) children enrolled in the WHEALS birth cohort study had a clinical

242 , a total of 57 articles with 4,651 patients enrolled in this meta-analysis.

243 or mixed episode per DSM-IV-TR criteria were enrolled in this randomized, placebo-controlled trial co

244 dominal pain who underwent abdominal CT were enrolled in this retrospective study.

245 Sixty patients were enrolled in this study: 30 patients affected by central

246 22, 2013, and Aug 10, 2015, 82 patients were enrolled, including 74 patients with small-cell lung can

247 domised, phase 2, open-label clinical trials enrolled individuals from 15 countries who were chronica

248 Of enrolled individuals, 47% had at least one P. vivax para

249 Of 1224 enrolled infants 6-11 months of age, records of 879 (72%

250 ver-blind, single-center study (NCT01193920) enrolled infants born to women previously randomized (1:

251 Fifty-eight of 61 enrolled infants had 4-week outcomes completed; mean bir

252 The median age of the 1005 enrolled infants was 3 months (interquartile range, 2-6

253 All cases of drug-induced liver injury enrolled into a prospective database over a 10-year peri

254 prior therapies (range, one to 13) were each enrolled into one of the four cohorts.

255 Participants were enrolled into the study between Jan 1, 2003, and March 3

256 t one child with unknown HIV status and were enrolled into the trial.

257 findings and investigations in 214 patients enrolled into the UK National Prion Monitoring Cohort St

258 ersonal Genome Project (PGP) is an effort to enroll many participants to create an open-access reposi

259 ptember 2014), 260 were eligible and 78 were enrolled (mean [SD] age, 16.5 [0.73] years), of whom 2 (

260 We enrolled men and postmenopausal or hysterectomised women

261 nd moderate/severe bleeding were assessed in enrolled (n = 25,416) and randomized (n = 11,554) subjec

262 We compared a cohort of patients enrolled on a trial of reduced-intensity allo-HSCT with

263 nts was 66 years, and 72% were men; 43% were enrolled on the basis of the ABI and 57% on the basis of

264 e reported, or if ten or fewer patients were enrolled or randomised.

265 , randomised, open-label, phase 3 trial that enrolled participants at 38 participating Children's Onc

266 children from 9 European birth cohorts that enrolled participants between 1996 and 2006.

267 The MACS enrolled participants through a range of community conta

268 ourse (2016), classrooms with a total of 364 enrolled participants were hosted at 20 institutions acr

269 We enrolled patients aged 18 years or older with HCV genoty

270 Results Trials enrolled patients from 1987 to 2011.

271 This observational case-control study enrolled patients from September 1, 2016, through May 31

272 F injections, as well as injections per 1000 enrolled patients per general category of ophthalmic dis

273 ts developed inhibitors to rFIXFc; in the 30 enrolled patients the most common adverse events were na

274 46 of 48 enrolled patients were assessable (two patients had unco

275 All enrolled patients were assessed for the primary outcome,

276 In this observational cohort study, we enrolled patients with idiopathic or heritable pulmonary

277 nal new drug authorization, we prospectively enrolled patients with newly diagnosed HL (n = 19) and N

278 We enrolled patients with primary refractory or relapsed my

279 the REE), and survival were recorded.Of 390 enrolled patients, 49% of subjects were hypermetabolic,

280 Among 63 enrolled patients, median age was 66 years (range, 30-92

281 ies in adults with unprovoked VTE that began enrolling patients after 1 January 2000 and had at least

282 Sita-Hospital) in five hospitals in the USA, enrolling patients aged 18-80 years with type 2 diabetes

283 h the second dose-expansion part ongoing and enrolling patients as of July 8, 2017, in Japan and the

284 hospitals in Philadelphia, Pennsylvania, and enrolling patients who spent at least 3 days in the ICU

285 tial numbers of harder-to-recruit women also enrolled (race/ethnicity other than non-Hispanic white:

286 Sixty-two patients were enrolled; the complete response rate among all treated p

287 articipating centers were fully compliant in enrolling their patients and the inclusion period was ex

288 0, 2010, and Nov 7, 2012, 1022 patients were enrolled to the trial, of whom 510 were assigned docetax

289 nducted from October 12, 2015 (first patient enrolled), to April 21, 2016 (last patient visit).

290 lind randomised placebo-controlled trial, we enrolled undiagnosed patients, aged 18-80 years, with co

291 In this single-arm, open-label trial, we enrolled virologically suppressed, HIV-infected children

292 women) of the planned 1100 patients had been enrolled with follow-up for a median of 15 months.

293 d 1522 in the postimplementation phase) were enrolled, with 1053 patients (43.5%) from the spoke heal

294 ry with expected LOS longer than 6 days were enrolled, with a recruitment rate of 65.3%.

295 levation myocardial infarction patients were enrolled within 12 hours from symptoms onset.

296 Sixty subjects (5-50 years old) were enrolled within 4 days of acute onset of upper respirato

297 cific antigen levels less than 50 ng/mL, and enrolled within 6 months of diagnosis.

298 We included children continuously enrolled within a month of birth through 15 months who r

299 centre, single-arm, phase 2 prevention study enrolled women aged 18 years and older with postmenopaus

300 Enrolled women presented more frequently with atypical c